{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:29:57Z","timestamp":1791386997129,"version":"4.3.3"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant Agency of Charles University","award":["1574217\/C\/2017"],"award-info":[{"award-number":["1574217\/C\/2017"]}]},{"name":"Grant Agency of Charles University","award":["2018\/260414"],"award-info":[{"award-number":["2018\/260414"]}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["17-16169S"],"award-info":[{"award-number":["17-16169S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EFSA-CDN","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000841"]}]},{"DOI":"10.13039\/501100008530","name":"ERDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.taap.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T18:17:07Z","timestamp":1549390627000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta"],"prefix":"10.1016","volume":"368","author":[{"given":"Rona","family":"Karahoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-7212","authenticated-orcid":false,"given":"Martina","family":"Ceckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Staud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6\u20137","key":"10.1016\/j.taap.2019.02.002_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.placenta.2005.06.008","article-title":"MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction","volume":"27","author":"Atkinson","year":"2006","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0b013e3181d6c9ed","article-title":"Lopinavir tablet pharmacokinetics with an increased dose during pregnancy","volume":"54","author":"Best","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr. (1999)"},{"issue":"13","key":"10.1016\/j.taap.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/01.aids.0000242814.42344.77","article-title":"Mitochondrial dysfunction following perinatal exposure to nucleoside analogues","volume":"20","author":"Blanche","year":"2006","journal-title":"AIDS (London, England)"},{"issue":"1\u20132","key":"10.1016\/j.taap.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1440-1681.2006.04324.x","article-title":"Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo","volume":"33","author":"Ceckova","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.taap.2019.02.002_bb0025","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1128\/AAC.00648-16","article-title":"Role of ABC and solute carrier transporters in the placental transport of lamivudine","volume":"60","author":"Ceckova","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.taap.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana","volume":"206","author":"Chen","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00002030-200003100-00029","article-title":"L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues","volume":"14","author":"Claessens","year":"2000","journal-title":"AIDS (London, England)"},{"issue":"10","key":"10.1016\/j.taap.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/civ587","article-title":"Maraviroc pharmacokinetics in HIV-1\u2013infected pregnant women","volume":"61","author":"Colbers","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.taap.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/503045","article-title":"Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?","volume":"193","author":"Cotter","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31823ff052","article-title":"Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum","volume":"59","author":"Cressey","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr. (1999)"},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2017.06.015","article-title":"Biochemical characteristics of newborns with carnitine transporter defect identified by newborn screening in California","volume":"122","author":"Gallant","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.taap.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/QAD.0000000000001066","article-title":"Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling","volume":"30","author":"Garcia-Otero","year":"2016","journal-title":"AIDS (London, England)"},{"issue":"15","key":"10.1016\/j.taap.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1097\/00002030-199910220-00011","article-title":"The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring","volume":"13","author":"Gatti","year":"1999","journal-title":"AIDS (London, England)"},{"issue":"9","key":"10.1016\/j.taap.2019.02.002_bb0070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/phar.1626","article-title":"Antiretroviral pharmacokinetics in pregnant women","volume":"35","author":"Gilbert","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/135965350901400309","article-title":"Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy","volume":"14","author":"Gingelmaier","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.taap.2019.02.002_bb0080","first-page":"241","article-title":"In vitro methods for studying human placental amino acid transport: placental plasma membrane vesicles","volume":"122","author":"Glazier","year":"2006","journal-title":"Methods Mol. Med."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0005-2736(88)90475-0","article-title":"Purification and Na+ uptake by human placental microvillus membrane vesicles prepared by three different methods","volume":"945","author":"Glazier","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2019.02.002_bb0090","first-page":"253","article-title":"In vitro methods for studying human placental amino acid transport placental villous fragments","volume":"122","author":"Greenwood","year":"2006","journal-title":"Methods Mol. Med."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/dmd.104.001560","article-title":"Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta","volume":"33","author":"Grube","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAD.0b013e32834f3232","article-title":"Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn","volume":"26","author":"Hernandez","year":"2012","journal-title":"AIDS (London, England)"},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000001334","article-title":"Placental mitochondrial toxicity, oxidative stress, apoptosis, and adverse perinatal outcomes in HIV pregnancies under antiretroviral treatment containing zidovudine","volume":"75","author":"Hernandez","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1\u20132","key":"10.1016\/j.taap.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2007.09.022","article-title":"The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo","volume":"351","author":"Hirano","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0272-0590(92)90155-B","article-title":"Maternal and fetal tissue distribution of L-carnitine in pregnant mice: low accumulation in the brain","volume":"19","author":"Kim","year":"1992","journal-title":"Fundam. Appl. Toxicol."},{"issue":"7","key":"10.1016\/j.taap.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00003088-200645070-00003","article-title":"Tipranavir: a novel nonpeptidic protease inhibitor of HIV","volume":"45","author":"King","year":"2006","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/mgme.2001.3207","article-title":"Carnitine transport by organic cation transporters and systemic carnitine deficiency","volume":"73","author":"Lahjouji","year":"2001","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0130","doi-asserted-by":"crossref","first-page":"C263","DOI":"10.1152\/ajpcell.00333.2003","article-title":"L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2","volume":"287","author":"Lahjouji","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"10018","key":"10.1016\/j.taap.2019.02.002_bb0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(15)00837-5","article-title":"Stillbirths: rates, risk factors, and acceleration towards 2030","volume":"387","author":"Lawn","year":"2016","journal-title":"Lancet (Lond., Eng.)"},{"key":"10.1016\/j.taap.2019.02.002_bb0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cyto.2018.05.001","article-title":"Plasma metabolic changes in Chinese HIV-infected patients receiving lopinavir\/ritonavir based treatment: implications for HIV precision therapy","volume":"110","author":"Li","year":"2018","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.taap.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bph.13004","article-title":"Inhibition of L-carnitine biosynthesis and transport by methyl-gamma-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction","volume":"172","author":"Liepinsh","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142C","author":"Longo","year":"2006","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1997.00001.x","article-title":"The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis","volume":"244","author":"McGarry","year":"1997","journal-title":"Eur. J. Biochem."},{"issue":"15","key":"10.1016\/j.taap.2019.02.002_bb0165","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003088-200443150-00002","article-title":"Pharmacokinetics of antiretrovirals in pregnant women","volume":"43","author":"Mirochnick","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2019.02.002_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2016.00239","article-title":"Etravirine pharmacokinetics in HIV-infected pregnant women","volume":"7","author":"Mulligan","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2019.02.002_bb0175","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/QAD.0000000000001755","article-title":"Dolutegravir pharmacokinetics in pregnant and postpartum women living with","volume":"32","author":"Mulligan","year":"2018","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.taap.2019.02.002_bb0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.reprotox.2015.07.070","article-title":"Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir","volume":"57","author":"Neumanova","year":"2015","journal-title":"Reprod. Toxicol. (Elmsford, NY)"},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1542\/peds.67.1.95","article-title":"Carnitine in the perinatal metabolism of lipids. I. Relationship between maternal and fetal plasma levels of carnitine and acylcarnitines","volume":"67","author":"Novak","year":"1981","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025163204165","article-title":"High activity of fatty acid oxidation enzymes in human placenta: implications for fetal-maternal disease","volume":"26","author":"Oey","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10545-006-0199-x","article-title":"Fatty acid oxidation in the human fetus: implications for fetal and adult disease","volume":"29","author":"Oey","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0200","first-page":"778","article-title":"Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance","volume":"291","author":"Ohashi","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2019.02.002_bb0205","author":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission"},{"issue":"5","key":"10.1016\/j.taap.2019.02.002_bb0215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/plac.2002.0808","article-title":"Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age","volume":"23","author":"Rakheja","year":"2002","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10545-013-9606-2","article-title":"Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands","volume":"37","author":"Rasmussen","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.taap.2019.02.002_bb0225","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbalip.2010.01.007","article-title":"HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters","volume":"1801","author":"Richmond","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"18","key":"10.1016\/j.taap.2019.02.002_bb0230","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e32825a69d1","article-title":"Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer","volume":"21","author":"Ripamonti","year":"2007","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0005-2736(96)00068-5","article-title":"Sodium-dependent high-affinity binding of carnitine to human placental brush border membranes","volume":"1282","author":"Roque","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1468-1293.2011.00945.x","article-title":"Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress","volume":"13","author":"Ross","year":"2012","journal-title":"HIV Med."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2125.2008.03220.x","article-title":"Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women","volume":"66","author":"Roustit","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0250","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1124\/jpet.104.072363","article-title":"Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells","volume":"312","author":"Rytting","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2019.02.002_bb0255","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1203\/00006450-198507000-00013","article-title":"Transfer and metabolism of carnitine and carnitine esters in the in vitro perfused human placenta","volume":"19","author":"Schmidt-Sommerfeld","year":"1985","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.taap.2019.02.002_bb0260","doi-asserted-by":"crossref","first-page":"E1098","DOI":"10.1152\/ajpendo.00481.2002","article-title":"Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases","volume":"284","author":"Shekhawat","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0265","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1203\/01.PDR.0000134252.02876.55","article-title":"Carnitine content and expression of mitochondrial beta-oxidation enzymes in placentas of wild-type (OCTN2(+\/+)) and OCTN2 Null (OCTN2(\u2212\/\u2212)) mice","volume":"56","author":"Shekhawat","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.taap.2019.02.002_bb0270","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.placenta.2018.06.312","article-title":"Embryonic lethality in mice due to carnitine transporter OCTN2 defect and placental carnitine deficiency","volume":"69","author":"Shekhawat","year":"2018","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001635","article-title":"Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1\/CO11)","volume":"11","author":"Sibiude","year":"2014","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.taap.2019.02.002_bb0280","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cid\/civ260","article-title":"In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial","volume":"61","author":"Sibiude","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijns3010001","article-title":"Neonatal screening for primary carnitine deficiency: lessons learned from the Faroe Islands","volume":"3","author":"Steuerwald","year":"2017","journal-title":"Int. J. Neonatal Screen."},{"issue":"7","key":"10.1016\/j.taap.2019.02.002_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199555","article-title":"Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy","volume":"13","author":"Stringer","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0295","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.108.146449","article-title":"Functional genetic variation in the basal promoter of the organic cation\/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)","volume":"329","author":"Tahara","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/bdd.1816","article-title":"Pharmacological and pathophysiological roles of carnitine\/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21)","volume":"34","author":"Tamai","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"The International Transporter Consortium","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.taap.2019.02.002_bb0315","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0000000000000968","article-title":"Pharmacokinetics of rilpivirine in HIV-infected pregnant women","volume":"72","author":"Tran","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.taap.2019.02.002_bb0330","author":"UN Joint Programme on HIV\/AIDS (UNAIDS)"},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0335","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3018(16)30195-3","article-title":"Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"4","author":"Uthman","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.taap.2019.02.002_bb0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fimmu.2016.00199","article-title":"The PHACS SMARTT study: assessment of the safety of in utero exposure to antiretroviral drugs","volume":"7","author":"Van Dyke","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2019.02.002_bb0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejogrb.2015.11.015","article-title":"Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry","volume":"197","author":"Vannappagari","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0350","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s005990050060","article-title":"Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs","volume":"29","author":"Verrotti","year":"1999","journal-title":"Int. J. Clin. Lab. Res."},{"issue":"8","key":"10.1016\/j.taap.2019.02.002_bb0355","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/135965350801300820","article-title":"Pharmacokinetics, safety and efficacy of saquinavir\/ritonavir 1,000\/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy","volume":"13","author":"von Hentig","year":"2008","journal-title":"Antivir. Ther."},{"issue":"4","key":"10.1016\/j.taap.2019.02.002_bb0360","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0000000000000318","article-title":"Raltegravir Pharmacokinetics during Pregnancy","volume":"67","author":"Watts","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.taap.2019.02.002_bb0365","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0370","first-page":"1482","article-title":"Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation\/carnitine transporter","volume":"290","author":"Wu","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.taap.2019.02.002_bb0375","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0013-9580.2004.29603.x","article-title":"Interaction between anticonvulsants and human placental carnitine transporter","volume":"45","author":"Wu","year":"2004","journal-title":"Epilepsia"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X19300432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X19300432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T12:24:05Z","timestamp":1662899045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X19300432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":72,"alternative-id":["S0041008X19300432"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2019.02.002","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}